Source: Eur Respir J 2007; 29: 1127-1137
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Siempos I. I., Dimopoulos G., Korbila I. P., Manta K., Falagas M. E.. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur Respir J 2007; 29: 1127-1137

Member's Comments

No comment yet.

Related content which might interest you: Microbiology of non-CF bronchiectasis Source: Eur Respir Mon 2011; 52: 68-96 Year: 2011 Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020 Year: 2021 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Study of the prevalence of Moraxella (Branhamella) catarrhalis in the patients suffering from lower respiratory tract infection Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Levofloxacin resistance among streptococcus pneumoniae isolates in a chronic disease hospital Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Source: Eur Respir J 2002; 20: 3S-8S Year: 2002